ArticleMedComm2025

Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.

Guangxu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.